Skip to main content

Dementia: Making a Diagnosis and Managing Behavioural and Psychological Symptoms

  • 1787 Accesses

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.

    Book  Google Scholar 

  2. World Health Organization. Dementia factsheet; 2015. www.who.int/mediacentre/factsheets/fs362/en/.

  3. O’Brien JT, Markus HS. Vascular risk factors and Alzheimer’s disease. BMC Med. 2014;12:218. doi:10.1186/s12916-014-0218-y.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Loy CT, Schofield PR, Turner AM, Kwok JBJ. Genetics of dementia. Lancet. 2014;383:828–40.

    Article  CAS  PubMed  Google Scholar 

  5. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.

    Article  CAS  PubMed  Google Scholar 

  6. Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges JR. Validation of the Addenbrooke’s Cognitive Examination III in frontotemporal dementia and Alzheimer’s disease. Dement Geriatr Cogn Disord. 2013;36:242–50.

    Article  PubMed  Google Scholar 

  7. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment (MoCA): a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.

    Article  PubMed  Google Scholar 

  8. Kang H, Zhao F, You L, Giorgetta C, Venkatesh D, Sarkhel S, Prakash R. Pseudo-dementia: a neuropsychological review. Ann Indian Acad Neurol. 2014;17:147–54. doi:10.4103/0972-2327.132613.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Jellinger KA, Attems J. Challenges of multimorbidity of the aging brain: a critical update. J Neural Transm. 2015;122(4):505–21. doi:10.1007/s00702-014-1288-x.

    Article  PubMed  Google Scholar 

  10. Langa KM, Foster NL, Larson EB. Mixed dementia: emerging concepts and therapeutic implications. JAMA. 2004;292(23):2901–8. doi:10.1001/jama.292.23.2901.

    Article  CAS  PubMed  Google Scholar 

  11. Di Carlo A, Lamassa M, Baldereschi M, Inzitari M, Scafato E, Farchi G, Inzitari D. CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia. Neurology. 2007;68:1909–16.

    Article  PubMed  Google Scholar 

  12. Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, McArdle JJ, Willis RJ, Wallace RB. Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med. 2008;148:427–34.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–8. [Erratum, Arch Neurol. 1999;56:760]

    Article  CAS  PubMed  Google Scholar 

  14. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270–9. doi:10.1016/j.jalz.2011.03.008.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Farias ST, Mungas D, Reed BR, Harvey D, DeCarli C. Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch Neurol. 2009;66(9):1151–7. doi:10.1001/archneurol.2009.106.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Querfurth HW, LaFerla FM. Alzheimer’s disease. N Engl J Med. 2010;362:329–44. doi:10.1056/NEJMra0909142.

    Article  CAS  PubMed  Google Scholar 

  17. Herholz K, Ebmeier K. Clinical amyloid imaging in Alzheimer’s disease. Lancet Neurol. 2011;10(7):667–70. doi:10.1016/S1474-4422(11)70123-5.

    Article  CAS  PubMed  Google Scholar 

  18. Blennow K, Zetterberg H. The past and the future of Alzheimer’s disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular events. Front Neurosci. 2015;9:345. doi:10.3389/fnins.2015.00345.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002;1:426–36.

    Article  PubMed  Google Scholar 

  20. Gupta D, Kuruvilla A. Vascular parkinsonism: what makes it different? Postgrad Med J. 2011;87:829–36. doi:10.1136/postgradmedj-2011-130051.

    Article  PubMed  Google Scholar 

  21. O’Brien JT, Thomas A. Vascular dementia. Lancet. 2015;386:1698–706. doi:10.1016/S0140-6736(15)00463-8.

    Article  PubMed  Google Scholar 

  22. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen ENH, Ballard C, de Vos RAI, Wilcock GK, Jellinger KA, Perry RH. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113–24.

    Article  CAS  PubMed  Google Scholar 

  23. Warren JD, Rohrer JD, Rossor MN. Frontotempoeral dementia. BMJ. 2013;347:f4827. doi:10.1136/bmj.f4827.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Rohrer JD, Guerreiro R, Vandrovcova J, Uphill J, Reiman D, Beck J, Isaacs AM, Authier A, Ferrari R, Fox NC, Mackenzie IRA, Warren JD, de Silva R, Holton J, Revesz T, Hardy J, Mead S, Rossor MN. The heritability and genetics of frontotemporal lobar degeneration. Neurology. 2009;73(18):1451–6. doi:10.1212/WNL.0b013e3181bf997a.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Turnbull Q, Wolf AMD, Holroyd S. Attitudes of elderly subjects toward “Truth Telling” for the diagnosis of Alzheimer’s disease. J Geriatr Psychiatry Neurol. 2002;16:90–3. doi:10.1177/0891988703016002005.

    Article  Google Scholar 

  26. Langa KM, Levine DA. The diagnosis and management of mild cognitive impairment: a clinical review. JAMA. 2014;312(23):2551–61. doi:10.1001/jama.2014.13806.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. National Institute for Health and Clinical Excellence. Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease. NICE technology appraisal guidance 217; 2011. http://guidance.nice.org.uk/TA217.

  28. Burns A, Yeates A, Akintade L, del Valle M, Zhang RY, Schwam EM, Perdomo CA. Defining treatment response to donepezil in Alzheimer’s disease: responder analysis of patient-level data from randomized, placebo-controlled studies. Drugs Aging. 2008;25(8):707–14.

    Article  CAS  PubMed  Google Scholar 

  29. Atri A, Hendrix SB, Pejović V, Hofbauer RK, Edwards J, Molinuevo JL, Graham SM. Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer’s dementia: a pooled area under the curve analysis. Alzheimers Res Ther. 2015;7(1):28. doi:10.1186/s13195-015-0109-2.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Farrimond LE, Roberts E, McShane R. Memantine and cholinesterase inhibitor combination therapy for Alzheimer’s disease: a systematic review. BMJ Open. 2012;2:e000917. doi:10.1136/bmjopen-2012-000917.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Stinton C, McKeith I, Taylor J, Lafortune L, Mioshi E, Mak E, Cambridge V, Mason J, Thomas A, O’Brien JT. Pharmacological management of Lewy body dementia: a systematic review and meta-analysis. Am J Psychiatry. 2015;172:731–42. doi:10.1176/appi.ajp.2015.14121582.

    Article  PubMed  Google Scholar 

  32. Goldman JG, Goetz CG, Brandabur M, Sanfilippo M, Stebbins GT. Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies. Mov Disord. 2008;23(15):2248–50. doi:10.1002/mds.22322.

    Article  PubMed  Google Scholar 

  33. Brodaty H, Draper BM, Low L. Behavioural and psychological symptoms of dementia: a seven tiered model of service delivery. Med J Aust. 2003;178(5):231–4.

    PubMed  Google Scholar 

  34. NSW Ministry of Health and Royal Australian and New Zealand College of Psychiatrists. Assessment and management of people with Behavioural and Psychological Symptoms of Dementia (BPSD): a handbook for NSW Health Clinicians; 2013. Accessible via www.health.nsw.gov.au or www.ranzcp.org.

  35. International Psychogeriatric Association. Thee IPA complete guides to behavioral and psychological symptoms of dementia; 2012. www.ipa-online.org.

  36. Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH, Brookhart MA. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med. 2005;353:2335–41. doi:10.1056/NEJMoa052827.

    Article  CAS  PubMed  Google Scholar 

  37. Kleijer BC, van Marum RJ, Egberts ACG, Jansen PAF, Frijters D, Heerdink ER, Ribbe MW. The course of behavioral problems in elderly nursing home patients with dementia when treated with antipsychotics. Int Psychogeriatr. 2009;21:931–40. doi:10.1017/S1041610209990524.

    Article  CAS  PubMed  Google Scholar 

  38. Finkel SI, Lyons JS, Anderson RL. A Brief Agitation Rating Scale (BARS) for nursing home elderly. J Am Geriatr Soc. 1993;41(1):50–2. doi:10.1111/j.1532-5415.1993.tb05948.x.

    Article  CAS  PubMed  Google Scholar 

  39. Holmes C, Wilkinson D, Dean C, Vethanayagam S, Olivieri S, Langley A, Pandita-Gunawardena ND, Hogg F, Clare C, Damms J. The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease. Neurology. 2004;63:214–9. doi:10.1212/01.WNL.0000129990.32253.7B.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Brendan Flynn FRANZCP, Cert Old Age Psych. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 The Editor(s)

About this chapter

Cite this chapter

Flynn, B. (2018). Dementia: Making a Diagnosis and Managing Behavioural and Psychological Symptoms. In: Nair, B. (eds) Geriatric Medicine. Springer, Singapore. https://doi.org/10.1007/978-981-10-3253-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-3253-0_6

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-3252-3

  • Online ISBN: 978-981-10-3253-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics